MedPath

INVOKANA

These highlights do not include all the information needed to use INVOKANA safely and effectively. See full prescribing information for INVOKANA. INVOKANA (canagliflozin) tablets, for oral use Initial U.S. Approval: 2013

Approved
Approval ID

5f76e16f-0c24-454a-81af-4080b312c940

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Apr 24, 2023

Manufacturers
FDA

Cardinal Health 107, LLC

DUNS: 118546603

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

canagliflozin

PRODUCT DETAILS

NDC Product Code55154-1426
Application NumberNDA204042
Marketing CategoryC73594
Route of AdministrationORAL
Effective DateDecember 13, 2018
Generic Namecanagliflozin

INGREDIENTS (11)

ANHYDROUS LACTOSEInactive
Code: 3SY5LH9PMK
Classification: IACT
canagliflozinActive
Quantity: 300 mg in 1 1
Code: 0SAC974Z85
Classification: ACTIM
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
POLYVINYL ALCOHOL, UNSPECIFIEDInactive
Code: 532B59J990
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
POLYETHYLENE GLYCOL 3350Inactive
Code: G2M7P15E5P
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
Hydroxypropyl Cellulose (1600000 WAMW)Inactive
Code: RFW2ET671P
Classification: IACT

canagliflozin

PRODUCT DETAILS

NDC Product Code55154-1425
Application NumberNDA204042
Marketing CategoryC73594
Route of AdministrationORAL
Effective DateDecember 13, 2018
Generic Namecanagliflozin

INGREDIENTS (12)

canagliflozinActive
Quantity: 100 mg in 1 1
Code: 0SAC974Z85
Classification: ACTIM
ANHYDROUS LACTOSEInactive
Code: 3SY5LH9PMK
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
POLYETHYLENE GLYCOL 3350Inactive
Code: G2M7P15E5P
Classification: IACT
POLYVINYL ALCOHOL, UNSPECIFIEDInactive
Code: 532B59J990
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
Hydroxypropyl Cellulose (1600000 WAMW)Inactive
Code: RFW2ET671P
Classification: IACT
FERRIC OXIDE YELLOWInactive
Code: EX438O2MRT
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

INVOKANA - FDA Drug Approval Details